ENSG

The Ensign Group Inc
NASDAQHEALTHCAREMEDICAL CARE FACILITIES

Key Statistics

Market Cap
$9.95B
P/E Ratio
26.73
EPS
$6.39
Beta
0.69
52W High
$217.84
52W Low
$141.52
50-Day MA
$174.35
200-Day MA
$182.34
Dividend Yield
0.15%
Profit Margin
6.90%
Forward P/E
20.33
PEG Ratio
1.36

About The Ensign Group Inc

The Ensign Group, Inc. provides health care services in the post-acute care continuum and other ancillary businesses. The company is headquartered in San Juan Capistrano, California.

Official WebsiteUSAFY End: December

Fundamentals

Revenue (TTM)$5.49B
Gross Profit (TTM)$908.93M
EBITDA$582.74M
Operating Margin9.04%
Return on Equity17.00%
Return on Assets5.49%
Revenue/Share (TTM)$95.13
Book Value$42.26
Price-to-Book4.11
Price-to-Sales (TTM)1.81
EV/Revenue2.179
EV/EBITDA19.24
Quarterly Earnings Growth (YoY)16.70%
Quarterly Revenue Growth (YoY)17.30%
Shares Outstanding$58.28M
Float$55.65M
% Insiders3.53%
% Institutions92.66%

Historical Volatility

HV 10-Day
21.02%
HV 20-Day
17.64%
HV 30-Day
21.16%
HV 60-Day
25.78%
HV Rank
43.7%

Volatility is currently contracting

Analyst Ratings

Consensus ($220.00 target)
1
Strong Buy
3
Buy
1
Hold

Latest News

Ensign Investor News: If You Have Suffered Losses in The Ensign Group, Inc. (NASDAQ: ENSG), You Are Encouraged to Contact The Rosen Law Firm About Your Rights

NEW YORK, Sept. 07, 2026 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm, continues to investigate potential securities claims on behalf of shareholders of The Ensign Group, Inc. (NASDAQ: ENSG) resulting from allegations that Ensign may have issued materially misleading business information to the investing public.

GlobeNewsWire9/7/2026Neutral
ROSEN, TOP RANKED GLOBAL COUNSEL, Encourages The Ensign Group, Inc. Investors to Inquire About Securities Class Action Investigation - ENSG

New York, New York--(Newsfile Corp. - September 6, 2026) - WHY: Rosen Law Firm, a global investor rights law firm, continues to investigate potential securities claims on behalf of shareholders of The Ensign Group, Inc. (NASDAQ: ENSG) resulting from allegations that Ensign may have issued materially misleading business information to the investing public. SO WHAT: If you purchased Ensign securities you may be entitled to compensation without payment of any out of pocket fees or costs through a contingency fee arrangement.

Newsfile Corp9/6/2026Neutral
Ensign Investor News: If You Have Suffered Losses in The Ensign Group, Inc. (NASDAQ: ENSG), You Are Encouraged to Contact The Rosen Law Firm About Your Rights

NEW YORK, Sept. 04, 2026 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm, continues to investigate potential securities claims on behalf of shareholders of The Ensign Group, Inc. (NASDAQ: ENSG) resulting from allegations that Ensign may have issued materially misleading business information to the investing public.

GlobeNewsWire9/4/2026Neutral
Kaplan Fox Urges Investors of The Ensign Group, Inc. (ENSG) with Losses to Contact the Firm

New York, New York--(Newsfile Corp. - September 4, 2026) - Kaplan Fox & Kilsheimer LLP is investigating potential securities violations against The Ensign Group, Inc. ("Ensign" or the "Company") (NASDAQ: ENSG). CLICK HERE TO RECEIVE MORE INFORMATION ABOUT THIS INVESTIGATION If you are an Ensign investor and have suffered losses, or if you have information that could assist in the Ensign investigation, you may CLICK HERE to contact us.

Newsfile Corp9/4/2026Neutral
ROSEN, A LONGSTANDING FIRM, Encourages The Ensign Group, Inc. Investors to Inquire About Securities Class Action Investigation - ENSG

New York, New York--(Newsfile Corp. - September 2, 2026) - WHY: Rosen Law Firm, a global investor rights law firm, continues to investigate potential securities claims on behalf of shareholders of The Ensign Group, Inc. (NASDAQ: ENSG) resulting from allegations that Ensign may have issued materially misleading business information to the investing public. SO WHAT: If you purchased Ensign securities you may be entitled to compensation without payment of any out of pocket fees or costs through a contingency fee arrangement.

Newsfile Corp9/3/2026Neutral
Ensign Investor News: If You Have Suffered Losses in The Ensign Group, Inc. (NASDAQ: ENSG), You Are Encouraged to Contact The Rosen Law Firm About Your Rights

NEW YORK, Sept. 01, 2026 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm, continues to investigate potential securities claims on behalf of shareholders of The Ensign Group, Inc. (NASDAQ: ENSG) resulting from allegations that Ensign may have issued materially misleading business information to the investing public.

GlobeNewsWire9/2/2026Neutral
Kaplan Fox is Investigating The Ensign Group, Inc. (ENSG) on Behalf of Shareholders for Possible Securities Law Violations

New York, New York--(Newsfile Corp. - August 31, 2026) - Kaplan Fox & Kilsheimer LLP is investigating potential securities violations against The Ensign Group, Inc. ("Ensign" or the "Company") (NASDAQ: ENSG). CLICK HERE TO RECEIVE MORE INFORMATION ABOUT THIS INVESTIGATION If you are an Ensign investor and have suffered losses, or if you have information that could assist in the Ensign investigation, you may CLICK HERE to contact us.

Newsfile Corp8/31/2026Neutral
Ensign Investor News: If You Have Suffered Losses in The Ensign Group, Inc. (NASDAQ: ENSG), You Are Encouraged to Contact The Rosen Law Firm About Your Rights

NEW YORK, Aug. 28, 2026 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm, continues to investigate potential securities claims on behalf of shareholders of The Ensign Group, Inc. (NASDAQ: ENSG) resulting from allegations that Ensign may have issued materially misleading business information to the investing public.

GlobeNewsWire8/28/2026Neutral
Kaplan Fox Advises Investors of The Ensign Group, Inc. (ENSG) to Contact the Firm Regarding a Securities Investigation

New York, New York--(Newsfile Corp. - August 28, 2026) - Kaplan Fox & Kilsheimer LLP is investigating potential securities violations against The Ensign Group, Inc. ("Ensign" or the "Company") (NASDAQ: ENSG). CLICK HERE TO RECEIVE MORE INFORMATION ABOUT THIS INVESTIGATION If you are an Ensign investor and have suffered losses, or if you have information that could assist in the Ensign investigation, you may CLICK HERE to contact us.

Newsfile Corp8/28/2026Neutral

Turn research into an automated options-selling system

Tiblio connects your broker and runs your put-and-call-writing strategy for you — on ENSG and any ticker you trade — then tracks every position and per-strategy win rate.

See how it works

More HEALTHCARE Stocks

Data last updated: 9/7/2026